Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 47 (11%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 375 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-03-08 | 211055 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-10-10 | 2017-10-27 | 24913 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-11-22 | 2017-12-22 | 30110 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-04-28 | 2021-12-07 | 138161 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-09-30 | 2021-12-07 | 146477 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2022-12-16 | 2023-01-23 | 178647 |
| CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72248 |
| CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-04-28 | 2021-10-27 | 138164 |
| CIPROFLOXACIN | 500MG | TABLET | Resolved | 2022-01-18 | 2023-01-23 | 152957 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2017-10-13 | 2017-11-10 | 25856 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-02-21 | 2018-03-09 | 40452 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2024-01-30 | 2024-03-02 | 217793 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-10-31 | 2017-11-10 | 27549 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-07-18 | 2023-09-25 | 198904 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-01-17 | 2024-04-11 | 216276 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-11-28 | 2017-12-16 | 30910 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-05-06 | 2019-06-28 | 83143 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-07-18 | 2023-08-28 | 198907 |
| METFORMIN | 500MG | TABLET | Resolved | 2023-08-29 | 2023-09-19 | 203144 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2021-03-17 | 2021-08-04 | 135815 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |